AMLX Competitors & Alternatives
Compare Amylyx Pharmaceuticals Inc with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
AMLX
Main Stock$13.73
Tradestie Score
51
Market Cap
$1.49B
Revenue Growth
-1.0%
Analyst Upside
+70.4%
Top Competitors
47 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corporation Class A
|
$33.57
|
$1.65B | 14.5 | 45 | Compare |
|
BCRX
BioCryst Pharmaceuticals Inc
|
$8.48
|
$1.55B | - | 55 | Compare |
|
AVDL
Avadel Pharmaceuticals plc Ordinary Share
|
$21.64
|
$1.46B | - | 62 | Compare |
|
EVO
Evotec SE American Depositary Shares
|
$2.97
|
$1.34B | - | 51 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$6.35
|
$1.29B | 84.6 | 57 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.70
|
$1.29B | - | 53 | Compare |
|
AMPH
Amphastar Pharmaceuticals, Inc.
|
$18.09
|
$1.25B | 10.7 | 51 | Compare |
|
DVAX
Dynavax Technologies Corporation
|
$15.50
|
$1.21B | - | 55 | Compare |
|
PCRX
Pacira BioSciences, Inc. Common Stock
|
$23.44
|
$1.14B | 171.6 | 50 | Compare |
|
COLL
Collegium Pharmaceutical, Inc. Common Stock
|
$34.37
|
$1.11B | 16.3 | 58 | Compare |
More AMLX Analysis
Data updated: May 21, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
47 stocks in this industry